Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F

Journal of Lipid Research

Volumn 53, Issue 8, 2012, Pages 1576-1587

  White, C Roger ^a,b   Datta, Geeta ^a,b   Buck, Amanda K W ^a   Chaddha, Manjula ^a   Reddy, Gautam ^a   Wilson, Landon ^d   Palgunachari, Mayakonda N ^a   Abbasi, Mohammad ^a   Anantharamaiah, G M ^a,c  

^a and Clinical Center   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cholesterol efflux; Hypochlorous acid; Oxidation; Tryptophan

Indexed keywords

ABC TRANSPORTER A1; ACETYLASPARTYLTRYPTOPHANYLPHENYLALANYLLYSYLALANYLPHENYLALANYLTYROSYLASPARTYLLYSYLVALYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYLGLUTAMYLALANYLPHENYLALANYLAMIDE; ACETYLTRYPTOPHANYLTRYPTOPHANYLPHENYLALANYLLYSYLALANYLPHENYLALANYLTYROSYLASPARTYLLYSYLVALYLALANYLGLUTAMYLLYSYLPHENYLALANYLLYSYLGLUTAMYLALANYLPHENYLALANYLAMIDE; ANTIOXIDANT; APOLIPOPROTEIN A1; CHOLESTEROL; HYPOCHLOROUS ACID; PHOSPHOLIPID; SYNTHETIC PEPTIDE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BINDING KINETICS; CHEMICAL MODIFICATION; CHOLESTEROL TRANSPORT; CONCENTRATION (PARAMETERS); FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; OXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; APOLIPOPROTEIN A-I; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CHOLESTEROL; HUMANS; HYPOCHLOROUS ACID; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDES; PEPTIDOMIMETICS; PROTEIN CONFORMATION;

EID: 84863809566     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M026278     Document Type: Article

References (45)

1. Zhang, R., M. L. Brennan, X. Fu, R. J. Aviles, G. L. Pearce, M. S. Penn, E. J. Topol, D. L. Sprecher, and S. L. Hazen. 2001. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 286: 2136-2142. (Pubitemid 34041599)
2. Hazen, S. L., and J. W. Heinecke. 1997. 3-Chlorotyrosine, a specifi c marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99: 2075-2081. (Pubitemid 27203762)
3. MacCallum, N. S., G. J. Quinlan, and T. W. Evans. 2007. The role of neutrophil-derived myeloperoxidase in organ dysfunction and sepsis. Intensive Care Med. 2007: 173-187.
4. Breckwoldt, M. O., J. W. Chen, L. Stangenberg, E. Aikawa, E. Rodriguez, S. Qiu, M. A. Moskowitz, and R. Weissleder. 2008. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl. Acad. Sci. USA. 105: 18584-18589.
5. Hawkins, C. L., D. I. Pattison, and M. J. Davies. 2003. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids. 25: 259-274. (Pubitemid 38041264)
6. Yang, C. Y., Z. W. Gu, M. Yang, S. N. Lin, A. J. Garcia-Prats, L. K. Rogers, S. E. Welty, and C. V. Smith. 1999. Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro. J. Lipid Res. 40: 686-698. (Pubitemid 29173772)
7. Carr, A. C., T. Tijerina, and B. Frei. 2000. Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein. Biochem. J. 346: 491-499. (Pubitemid 30148138)
8. Chantepie, S., E. Malle, W. Sattler, M. J. Chapman, and A. Kontush. 2009. Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl. Arch. Biochem. Biophys. 487: 28-35.
9. Panzenboeck, U., S. Raitmayer, H. Reicher, H. Lindner, O. Glatter, E. Malle, and W. Sattler. 1997. Effects of reagent and enzymatically generated hypochlorite on physiochemical and metabolic properties of high density lipoproteins. J. Biol. Chem. 272: 29711-29720. (Pubitemid 27508065)
10. Malle, E., G. Marsche, U. Panzenboeck, and W. Sattler. 2006. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch. Biochem. Biophys. 445: 245-255. (Pubitemid 43082217)
11. Undurti, A., Y. Huang, J. A. Lupica, J. D. Smith, J. A. DiDonato, and S. L. Hazen. 2009. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J. Biol. Chem. 284: 30825-30835.
12. Marsche, G., A. Hammer, O. Oskolkova, K. F. Kozarsky, W. Sattler, and E. Malle. 2002. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J. Biol. Chem. 277: 32172-32179. (Pubitemid 34969031)
13. Guertin, F., S. Brunet, D. Lairon, and E. Levy. 1997. Oxidative tyrosylation of high density lipoprotein impairs biliary sterol secretion in rats. Atherosclerosis. 131: 35-41. (Pubitemid 27240094)
14. Pirillo, A., P. Uboldi, and A. L. Catapano. 2010. Dual effect of HOCl in the modification of high density lipoproteins. Biochem. Biophys. Res. Commun. 403: 447-451.
15. Shao, B., S. Pennathur, I. Pagani, M. Oda, J. L. Witztum, J. F. Oram, and J. W. Heinecke. 2010. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. J. Biol. Chem. 285: 18473-18484.
16. Shao, B., C. Bergt, X. Fu, P. Green, J. C. Voss, M. N. Oda, J. F. Oram, and J. W. Heinecke. 2005. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J. Biol. Chem. 280: 5983-5993. (Pubitemid 40280082)
17. Zheng, L., B. Nukana, M. L. Brennan, M. Sun, M. Goormastic, M. Settle, D. Schmitt, X. Fu, L. Thomson, P. L. Fox, et al. 2004. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114: 529-541. (Pubitemid 39572103)
18. Shao, B., G. Cavigiiolio, N. Brot, M. Oda, and J. W. Heinecke. 2008. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 105: 12224-12229.
19. Bergt, C., S. Pennathur, X. Fu, J. Byun, K. O. O'Brien, T. O. McDonald, P. Singh, G. M. Anantharamaiah, A. Chait, J. Brunzell, et al. 2004. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA. 101: 13032-13037. (Pubitemid 39167578)
20. Peng, D. Q., G. Brubaker, Z. Wu, L. Zheng, B. Willard, M. Kinter, S. L. Hazen, and J. D. Smith. 2008. Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function. Arterioscler. Thromb. Vasc. Biol. 28: 2063-2070.
21. Pattison, D. I., and M. J. Davies. 2001. Absolute rate constants for the reaction of hypochlorous acid with protein side-chains and peptide bonds. Chem. Res. Toxicol. 14: 1453-1464. (Pubitemid 32983270)
22. Shao, B., C. Tang, J. W. Heinecke, and J. F. Oram. 2010. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J. Lipid Res. 51: 1849-1858.
23. Zheng, L., M. Settle, G. Brubaker, D. Schmitt, S. L. Hazen, J. D. Smith, and M. Kinter. 2005. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1- dependent cholesterol efflux from macrophages. J. Biol. Chem. 280: 38-47. (Pubitemid 40164962)
24. Bergt, C., X. Fu, N. P. Huq, J. Kao, and J. W. Heinecke. 2004. Lysine residues direct the chlorination of tyrosines in Y XX K motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J. Biol. Chem. 279: 7856-7866. (Pubitemid 38294672)
25. Peng, D. Q., Z. Wu, G. Brubaker, L. Zheng, M. Settle, E. Gross, M. Kinter, S. L. Hazen, and J. D. Smith. 2005. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities. J. Biol. Chem. 280: 33775-33784. (Pubitemid 41443096)
26. Navab, M., G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, G. Hough, A. Wagner, K. Nakamura, D. W. Garber, G. Datta, J. P. Segrest, et al. 2004. Human apolipoprotein AI and A-I mimetic peptides: potential for atherosclerosis reversal. Curr. Opin. Lipidol. 15: 645-649. (Pubitemid 39612982)
27. Smythies, L. E., C. R. White, A. Maheshwari, M. Palgunachari, G. M. Anantharamaiah, M. Chaddha, A. R. Kurundkar, and G. Datta. 2010. The apolipoprotein A-I mimetic, 4F, alters the function of human monocyte-derived macrophages. Am. J. Physiol. Cell Physiol. 298: C1538-C1548.
28. Wool, G. D., C. A. Reardon, and G. S. Getz. 2008. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J. Lipid Res. 49: 1268-1283.
29. Van Lenten, B. J., A. C. Wagner, C. L. Jung, P. Ruchala, A. J. Waring, R. I. Lehrer, A. D. Watson, S. Hama, M. Navab, G. M. Anantharamaiah, et al. 2008. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J. Lipid Res. 49: 2302-2311.
30. Datta, G., M. Chaddha, S. Hama, M. Navab, A. M. Fogelman, D. W. Garber, V. K. Mishra, R. M. Epand, R. F. Epand, S. Lund-Katz, et al. 2001. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J. Lipid Res. 42: 1096-1104. (Pubitemid 32645791)
31. Meriwether, D., S. Imaizumi, V. Grijalva, G. Hough, L. Vakili, G. M. Anantharamaiah, R. Farias-Eisner, M. Navab, A. M. Fogelman, S. T. Reddy, et al. 2011. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. J. Lipid Res. 52: 1795-1809.
32. Kritharides, L., A. Christian, G. Stoudt, D. Morel, and G. H. Rothblat. 1998. Cholesterol metabolism and efflux in human THP-1 macrophages. Arterioscler. Thromb. Vasc. Biol. 18: 1589-1599. (Pubitemid 28465411)
33. Rodrigues, M. R., D. Rodriguez, M. Russo, and A. Campa. 2002. Macrophage activation includes high intracellular myeloperoxidase activity. Biochem. Biophys. Res. Commun. 292: 869-873. (Pubitemid 34687284)
34. Odobasic, D., A. R. Kitching, T. J. Semple, and S. R. Holdsworth. 2007. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T-cell immunity inducing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 18: 760-770. (Pubitemid 46434493)
35. Baldus, S., J. P. Eiserich, A. Mani, L. Castro, M. Figueroa, P. Chumley, W. Ma, A. Tousson, C. R. White, D. C. Bullard, et al. 2001. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108: 1759-1770. (Pubitemid 34015121)
36. Szuchman-Sapir, A. J., D. I. Pattison, N. A. Ellis, C. L. Hawkins, M. J. Davies, and P. K. Witting. 2008. Hypochlorous acid oxidizes methionine and tryptophan residues in myoglobin. Free Radic. Biol. Med. 45: 789-798.
37. Barter, P. J., S. Nicholls, K. A. Rye, G. M. Anantharamaiah, M. Navab, and A. M. Fogelman. 2004. Antiinflammatory properties of HDL. Circ. Res. 95: 764-772. (Pubitemid 39390578)
38. Dai, L., G. Datta, Z. Zhang, R. Patel, J. Honavar, S. Modi, M. Chaddha, M. Palgunachari, J. M. Wyss, H. Gupta, et al. 2010. The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats. J. Lipid Res. 51: 2695-2705.
39. Wimley, W. C., and S. H. White. 1996. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3: 842-848. (Pubitemid 26330634)
40. Hall, B. A., J. A. Armetage, and M. S. P. Sansom. 2011. Transmembrane helix dynamics of bacterial chemoreceptors support a piston model of signelling. PLoS Comput. Biol. 7: e1002204.
41. Moosmann, B., and C. Behel. 2000. Cytoprotective and anti-oxidant functions of Trp and Tyr residues in transmembrane proteins. Eur. J. Biochem. 267: 5687-5692.
42. White, C. R., G. Datta, A. Wake, Z. Zhang, H. Gupta, D. W. Garber, V. K. Mishra, M. N. Palgunachari, S. P. Handattu, M. Chaddha, et al. 2008. HDL therapy for cardiovascular diseases: the road to HDL mimetics. Curr. Atheroscler. Rep. 10: 405-412.
43. Navab, M., G. M. Anantharamaiah, S. Hama, D. W. Garber, M. Chaddha, G. Hough, R. Lallone, and A. M. Fogelman. 2002. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 105: 290-292. (Pubitemid 34106174)
44. Buga, G. M., J. S. Frank, G. A. Mottino, A. Hakhamian, A. Narasimha, A. D. Watson, B. Yekta, M. Navab, S. T. Reddy, G. M. Anantharamaiah, et al. 2008. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptornull mice fed a Western diet. J. Lipid Res. 49: 192-205.
45. Kruger, A. L., S. Peterson, S. Turkseven, P. M. Kaminski, F. F. Zhang, S. Quan, M. S. Wolin, and N. G. Abraham. 2005. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation. 111: 3126-3134. (Pubitemid 40847791)